Detailed Insights on Glucokinase - H2 2020 Pipeline Review - ResearchAndMarkets.com
Retrieved on:
Tuesday, April 6, 2021
The "Glucokinase - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Glucokinase - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
- Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules.
- The latest report Glucokinase - Pipeline Review, H2 2020, outlays comprehensive information on the Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
- Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Glucokinase is an enzyme that catalyzes the initial step in utilization of glucose by the beta-cell and liver at physiological glucose concentration.